Balance Sheet

Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

National Fuel Gas (NFG) Asset Writedowns and Impairment (2016 - 2024)

National Fuel Gas (NFG) has disclosed Asset Writedowns and Impairment for 5 consecutive years, with $141.8 million as the latest value for Q4 2024.

Quarterly Asset Writedowns and Impairment changed N/A to $141.8 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $141.8 million through Sep 2025, down 72.68% year-over-year, with the annual reading at $141.8 million for FY2025, 72.68% down from the prior year.
Asset Writedowns and Impairment hit $141.8 million in Q4 2024 for National Fuel Gas, down from $318.4 million in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $318.4 million in Q3 2024 to a low of $18.2 million in Q2 2020.